High Court Denies Helsinn's Bid To Stay On-Sale Bar Ruling
The U.S. Supreme Court on Thursday shot down Helsinn Healthcare's bid to hit pause on a Federal Circuit decision invalidating four Helsinn patents related to an anti-nausea drug under the America...To view the full article, register now.
Already a subscriber? Click here to view full article